World-renowned health and medical experts, including Prof Chris Semsarian (Head of the Centenary Institute’s Molecular Cardiology Program) came together at the University of Sydney to explore some of the key issues surrounding precision medicine.
In a thought-provoking panel discussion, issues on disease prediction, economics, ethics, clinical applications and the balance between the personal and the public benefit took place.
Listen now or available for download from the Radio National ‘Big Ideas’ website.
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis.